The U.S. Food and Drug Administration (FDA) has approved beginning clinical trials testing XTMAB-16, Xentria’s investigational TNF-alpha inhibitor for the treatment of sarcoidosis. The first, a Phase 1 trial evaluating the therapy in healthy volunteers, is expected to start in July at the Parexel Baltimore Early Phase…

A researcher investigating pathogens — disease-causing microorganisms — capable of causing neurosarcoidosis has been awarded $150,000 from the Foundation for Sarcoidosis Research (FSR). The FSR Sarcoidosis Research Fellowship Grant will provide Paula Barreras, MD, of the Johns Hopkins University Hospital, with two years of funding for her project. Titled…

A rare case of sarcoidosis affecting only the spleen was successfully diagnosed using tissue analysis, after imaging scans and lab tests failed, a case study reported. Sarcoidosis should be considered when multiple tumors in the spleen have been detected, the scientists recommended.  The…

Seeing actor Will Smith post that he was in the worst shape of his life made me smile. Because grinning in short shorts with his paunch on display, he shamelessly owned something I’ve often felt.   Getting and staying fit is tough. Sarcoidosis and other chronic illnesses don’t…